Details of the Drug

General Information of Drug (ID: DM6GBKI)

Drug Name

Trastuzumab duocarmazine

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 3	[1]
------------------------------------------------------------------------------------

ATC Code

L01FD05: Trastuzumab duocarmazine

L01FD: HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors

L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

L01: ANTINEOPLASTIC AGENTS

L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Drug Type

Antibody drug conjugate

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)